Press "Enter" to skip to content

Second doses started to be administered in the Phase-2 study of the native VLP vaccine


Industry and Technology Minister Mustafa Varank made a statement regarding the domestic corona virus vaccine based on virus-like particles (VLP).

Speaking in Sinop, Minister Varank emphasized that they are carrying out vaccine development studies with the contributions of scientists from all over Turkey through the TUBITAK COVID-19 Turkey Platform.

Varank continued his words as follows:

“One of them is our VLP vaccine candidate based on a very innovative technology. I also volunteered in the first human trials of the VLP vaccine. We passed the Phase-2 stage in the VLP vaccine. We completed the 1st dose vaccinations in the Phase-2 studies, the 2nd dose of vaccines started to be administered. No side effects have been observed in any of our volunteers until now.

After the second doses are applied and the results from the volunteers are evaluated, we will move on to the last phase, Phase-3. Even if all processes are completed positively, we will have our native VLP vaccine. We will be making a contribution to the fight against the scourge of Covid-19 from Turkey to the whole world.”

Download the NTV application, be informed about the developments


Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *